HALL BRETT MATTHEW (Chief Scientific Officer) purchased 1.6% of their position (6.04K shares) of IMMUNEERING CORP on the open market
Open‑market purchase worth $25.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/16/2026ACC: 0001790340-26-000076
Officer· Chief Scientific Officer
Since Jul 2021
+6.04K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6.04K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+6.04K
Price / share
$4.15
Trade value
$25.05K
% of position
1.6%
6/15/2026
376.50K→382.53K
Total
Net shares
+6.04K
Net value
$25.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/15/2026 | P · Purchase | +6.04K | $4.15 | $25.05K | 1.6% | 376.50K | 382.53K |
| Total | +6.04K | $25.05K | ||||||
Derivative Transactions0
No derivative transactions reported